Subacromial Impingement Syndrome Approach Using High Intensity Laser Therapy
Effectiveness of High Intensity Laser Therapy in the Treatment of Subacromial Impingement Syndrome
1 other identifier
interventional
46
1 country
1
Brief Summary
The purpose of this study is to assess the effectiveness of high intensity laser therapy in the treatment of subacromial impingement syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 15, 2016
CompletedFirst Posted
Study publicly available on registry
November 22, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedNovember 8, 2017
March 1, 2017
8 months
November 15, 2016
November 6, 2017
Conditions
Outcome Measures
Primary Outcomes (12)
Shoulder Pain and Disability Index (SPADI)
SPADI test
Baseline
Shoulder Pain and Disability Index (SPADI)
SPADI test
At the end of the laser protocol treatment (1 daily session during 15 workday -from monday to friday-)
Shoulder Pain and Disability Index (SPADI)
SPADI test
one month after the end of the protocol treatment
Shoulder Pain and Disability Index (SPADI)
SPADI test
three months after the end of the protocol treatment
Constant-Murley Score
Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points.
Baseline
Constant-Murley Score
Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points.
At the end of the laser protocol treatment (1 daily session during 15 workday -from monday to friday-)
Constant-Murley Score
Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points.
one month after the end of the protocol treatment
Constant-Murley Score
Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points.
three months after the end of the protocol treatment
Quick-Dash Abbreviated
Quick- Dash Abbreviated test
Baseline
Quick-Dash Abbreviated
Quick- Dash Abbreviated test
At the end of the laser protocol treatment (1 daily session during 15 workday -from monday to friday-)
Quick-Dash Abbreviated
Quick- Dash Abbreviated test
one month after the end of the protocol treatment
Quick-Dash Abbreviated
Quick- Dash Abbreviated test
three months after the end of the protocol treatment
Secondary Outcomes (3)
Painful pressure threshold
Baseline, at the of the 15 sessions, one month after the end of the protocol treatment, three months after the end of the protocol treatment
Painful pressure threshold after first session
First session - 15 minutes after laser or sham treatment.
VAS
Baseline, at the of the 15 sessions, one month after the end of the protocol treatment, three months after the end of the protocol treatment
Other Outcomes (1)
Quality of life
Baseline
Study Arms (2)
High-intensity laser therapy
EXPERIMENTALHigh-intensity laser therapy application through iLux Laser device
Sham device
SHAM COMPARATORSham high-intensity laser therapy application through sham iLux Laser device
Interventions
Treatment during 15 sessions. It is divided in two phases: 1. 12W. 50 Hz 20% duty cycle. 50 J/cm² in painful zone. 2. 15 W. Burst (10 pulses-900 msec each train) 250 J/cm² in painful zone. Trough the iLux Laser (Mectronic Medicale, Italy) \+ Physical Therapy protocol.
Sham treatment during 15 sessions trough the iLux Laser (Mectronic Medicale, Italy), It is applies the same time than experimental one but with 0 W + Physical Therapy protocol.
Eligibility Criteria
You may qualify if:
- Patients between 18 and 75 years old with diagnosis of subacromial impingement syndrome or any of the pathologies that compose it (tendinosis-tendinitis supraspinatus and rest of the rotator cuff, subacromial bursitis and tendinitis of the long head of the biceps).
- Visual Analogue Scale (VAS) less than or equal to 7.
- Forward flexion at least of 100º
You may not qualify if:
- Calcific tendinitis
- Complete rupture of the rotator cuff.
- Adhesive capsulitis.
- Clinical history of pathologies that without affecting the shoulder joint refer to painful shoulder symptoms (cervical root involvement, cervical surgery, cervical osteoarthritis and neurological pathologies)
- Fibromyalgia
- Be receiving physiotherapeutic treatment or have received it previously for this pathology one month before the start of treatment.
- Patients with alterations of thermal sensitivity.
- Derived from the absolute and relative contraindications of Laser Therapy:
- Photosensitive patients
- Neoplastic processes
- Hyperthyroidism
- Pregnancy
- Patients with a history of epileptic seizures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Castilla-La Manchalead
- Castilla-La Mancha Health Servicecollaborator
- Hospital General Nuestra Señora del Pradocollaborator
Study Sites (1)
Hospital General Nuestra Señora del Prado
Talavera de la Reina, Toledo, 45600, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Javier Aceituno-Gomez, PT
Castilla-La Mancha Health Service
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2016
First Posted
November 22, 2016
Study Start
November 1, 2016
Primary Completion
July 1, 2017
Study Completion
July 1, 2017
Last Updated
November 8, 2017
Record last verified: 2017-03